Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
HemoGenyx
3121
HemoGenyx
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
HemoGenyx, a privately held biopharmaceutical company, is developing new sources of hemogenic cells for hematopoietic system regeneration.
Suggest edits
Raised
$1.3M
Follow us
Companies in the same industry
Eiger BioPharmaceuticals, Inc.
Mitochon Pharmaceuticals
AnaBios Corporation
New Haven Pharmaceuticals, Inc.
Castle Creek Pharmaceuticals
Promentis Pharmaceuticals
Glyscend Incorporated
Avro Life Science
Lumobiotics
OWKIN
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$1,000,000
Seed fund - 2016
$250,000
Seed fund - 2014
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when HemoGenyx makes some noise.
